Reference — Oncology
Cancer Warning Signs
Early cancer detection significantly improves outcomes. Nurses play a critical role in health education, symptom recognition, and facilitating timely screening and diagnostic evaluation. This reference covers the CAUTION mnemonic, constitutional symptoms, and site-specific warning signs.
Educational use only. This material supports nursing education and exam review. It is not medical advice and is not a substitute for clinical judgment, institutional policy, or medical direction. Always follow facility protocols and current provider orders.
CAUTION Mnemonic — American Cancer Society
| Letter | Warning Sign | Commonly Associated Cancers | Nursing Education Point |
|---|---|---|---|
| C | Change in bowel or bladder habits | Colorectal, bladder, prostate | Persistent change — not a 1-day episode. Blood in stool or urine: report immediately. |
| A | A sore that does not heal | Oral, lip, skin (squamous cell) | Any non-healing ulcer, wound, or lesion >3 weeks warrants evaluation |
| U | Unusual bleeding or discharge | Uterine, cervical, colorectal, bladder, lung | Post-menopausal vaginal bleeding is abnormal and requires immediate evaluation |
| T | Thickening or lump in breast, testes, or elsewhere | Breast, testicular, thyroid, lymphoma | Teach self-exam: BSE monthly, TSE monthly. Any new or changing lump → evaluation |
| I | Indigestion or difficulty swallowing | Esophageal, gastric, head and neck, lung | Persistent dysphagia or heartburn unresponsive to treatment warrants endoscopy |
| O | Obvious change in wart or mole | Melanoma, basal cell, squamous cell carcinoma | ABCDE of melanoma: Asymmetry, Border, Color, Diameter >6mm, Evolution |
| N | Nagging cough or hoarseness | Lung, laryngeal, thyroid | Cough lasting >3 weeks, hemoptysis, or unexplained hoarseness requires evaluation |
Constitutional Symptoms — “B Symptoms”
“B symptoms” is the clinical term for the classic constitutional triad associated with hematologic malignancies. Their presence in Hodgkin lymphoma staging changes stage classification (e.g., Stage IIB vs. IIA) and worsens prognosis.
Fever
Unexplained fever >38°C (100.4°F) not due to infection. Often low-grade and intermittent ('Pel-Ebstein fever' pattern in classic Hodgkin lymphoma).
Hodgkin lymphoma, NHL, leukemia, renal cell carcinoma, hepatocellular carcinoma
Night sweats
Drenching night sweats that require change of clothes or bedding. Distinguish from menopausal hot flashes — cancer-related night sweats are classically severe.
Hodgkin lymphoma, NHL, leukemia, carcinoid, pheochromocytoma
Weight loss
Unintentional loss of ≥10% body weight over 6 months. Cancer cachexia: complex syndrome of anorexia, muscle wasting, and metabolic changes.
Any advanced malignancy; especially pancreatic, gastric, lung, and hematologic cancers
Other constitutional symptoms: fatigue (universal in cancer), anorexia, early satiety, generalized weakness, pruritus (especially in Hodgkin lymphoma and polycythemia vera).
Site-Specific Warning Signs
| Cancer Type | Warning Signs | Screening Tool |
|---|---|---|
| Breast | New breast lump or thickening, nipple discharge (especially bloody), nipple inversion, dimpling or peau d'orange skin change, axillary lymphadenopathy, breast asymmetry or shape change | Mammogram (USPSTF 2024: biennial age 40–74; ACS: annual age 45–54, then biennial, with option to start at 40); clinical breast exam; breast self-awareness |
| Colorectal | Change in bowel habits (new constipation or diarrhea), rectal bleeding or blood in stool, dark tarry stools, narrow stools, abdominal pain/cramping, feeling of incomplete evacuation, unexplained weight loss, anemia (fatigue, pallor) | Colonoscopy (every 10 years starting age 45 for average risk); FIT or FOBT (annually); CT colonography |
| Lung | Persistent cough (new or changed from baseline), hemoptysis, dyspnea, chest pain, hoarseness, recurrent pneumonia or bronchitis, unexplained weight loss, finger clubbing (late) | Low-dose CT (LDCT) annually: age 50–80, 20 pack-year history, current smoker or quit within 15 years (USPSTF 2021) |
| Prostate | Urinary frequency (especially nocturia), weak or interrupted urine stream, difficulty starting or stopping urination, dysuria, hematuria, hematospermia, back/hip/pelvic pain (bone metastasis) | PSA blood test + digital rectal exam (DRE) — shared decision-making discussion starting age 50; age 45 for high risk (Black men, family history) |
| Skin (Melanoma) | New mole or changing mole — use ABCDE: Asymmetry, irregular Border, varied Color (multiple shades), Diameter >6mm (pencil eraser), Evolution (any new change). Also: non-healing sore, pearly or waxy bump (basal cell) | Annual skin exam by dermatologist for high-risk patients; monthly self-skin exam |
| Cervical | Abnormal vaginal bleeding (especially post-coital, between periods, or post-menopausal), unusual vaginal discharge (watery, bloody, foul-smelling), pelvic pain | Pap smear (every 3 years starting age 21); co-test Pap + HPV (every 5 years for age 30–65); HPV vaccine (reduces risk) |
| Ovarian | Bloating (persistent), pelvic or abdominal pain, difficulty eating or early satiety, urinary urgency or frequency — symptoms often vague and late; frequently presents at advanced stage | No validated population-level screening tool; CA-125 and transvaginal ultrasound used in high-risk women (BRCA1/2) |
| Testicular | Painless lump or swelling in one testicle, feeling of heaviness in scrotum, dull ache in lower abdomen or groin, gynecomastia (beta-hCG secreting tumors) | Monthly testicular self-examination; ultrasound if abnormality detected |
Melanoma ABCDE Rule
A
Asymmetry
One half does not match the other
B
Border
Irregular, ragged, notched, or blurred edges
C
Color
Variation — multiple shades of brown, black, red, white, or blue
D
Diameter
Larger than 6mm (size of pencil eraser)
E
Evolution
Any new or changing mole — size, shape, color, or new symptom (bleeding, itching)
NCLEX Pearls — Cancer Warning Signs
Related Resources
Standards & sources
Fact-checked Jun 21, 2026This page is written to align with Oncology Nursing Society (ONS) · National Comprehensive Cancer Network (NCCN) · American Society of Clinical Oncology (ASCO). It is an educational summary, not a citation of any single document — always verify specific doses, values, and protocols against current guidelines and your facility policy. How we source content →
